SCHEMBL17829468

SCHEMBL17829468

Cc1cc(N)nc2cc3c(cc12)OC(C)(C)C=C3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
CA7 P43166 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA9 Q16790 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
HSD17B10 Q99714 1/20 0.40
BACE1 P56817 1/20 0.40
CYP3A4 P08684 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HIF1A Q16665 3/20 0.37
EPAS1 Q99814 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011114 0.86 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL2007092 0.83 KDM4E (0.40) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL2012483 0.80 ALDH1A1 (0.38) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL12580424 0.80 ALDH1A1 (0.38) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL2010551 0.77 HIF1A (0.43) ALDH1A1HPGDKDM4ENPC1CA12
Maleic Acid SCHEMBL17095080 0.77 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPC1CA12
Fumaric Acid SCHEMBL17095081 0.77 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL12580746 0.76 ALDH1A1 (0.44) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL2009298 0.76 ALDH1A1 (0.41) ALDH1A1HPGDKDM4ENPC1CA12
SCHEMBL2012649 0.74 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPC1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160168161-A1 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND NISSAN CHEMICAL INDUSTIES, LTD. (JP) 2016-06-16 US disclosed
US-20160168161-A1 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND NISSAN CHEMICAL INDUSTIES, LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168161-A1 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAT1, NAT10 ALDH1A1 2486/4885HPGD 93/4885KDM4E 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.